Pacemaker Battery Supplier Focuses On Nano R&D As Guidant Orders Slip
This article was originally published in The Gray Sheet
Executive Summary
Wilson Greatbatch plans to curb reliance on Guidant by building on a 31% growth rate for second-quarter sales of pacemaker batteries to other cardiac rhythm management firms
You may also be interested in...
Greatbatch Component Sales Benefit From Guidant’s Cardiac Device Woes
Greatbatch attributes short-term demand for its cardiac rhythm management (CRM) components to Guidant's recent ICD and pacemaker recalls
Greatbatch Component Sales Benefit From Guidant’s Cardiac Device Woes
Greatbatch attributes short-term demand for its cardiac rhythm management (CRM) components to Guidant's recent ICD and pacemaker recalls
Wilson Greatbatch readies nanobattery
St. Jude will receive the first shipment of Nano Silver Vanadium Oxide (SVO) batteries by mid year, Wilson Greatbatch says. Prior to that, the firm will conduct final testing on 1,000 Nano SVOs that already have been built, President & CEO Ed Voboril states in a March 30 presentation at Lehman Brothers Global Healthcare Conference in South Beach, Fla. The nanobattery, created via a laser-based nanomaterials synthesis process, will be used in St. Jude pacemakers. Wilson Greatbatch will release the battery to other potential buyers at the end of 2005 (1"The Gray Sheet" Aug. 16, 2004, p. 29)...